Treatment of neuroendocrine tumours with 177Lu‐peptide receptor radionuclide therapy: Challenging clinical scenarios and their management
Article in Journal of Neuroendocrinology (January 2022)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
A Case of 177Lu-DOTATATE Therapy Without the Use of Antiemetics
Article in Journal of Nuclear Medicine Technology (July 2021)
Severe metabolic acidosis and hyperkalemia after peptide receptor radionuclide therapy. A case report, review of the literature and proposed treatment algorithm
Article in Journal of Onco-Nephrology (June 2021)